The first-annual HALT HCC LA conference will take place April 14, 2018, at Huntington Medical Research Institutes’ (HMRI) new science and technology building in the Engemann Family Auditorium located in Pasadena, California. The one-day conference is designed to meet the educational needs of oncologists, hepatologists, gastroenterologists, interventional radiologists, surgeons and other healthcare professionals who treat and manage patients with HCC. Expert faculty will present emerging data on new treatment options, evolving data on existing treatment and diagnostic modalities and critical information on improving patient outcomes. The conference will be co-chaired by the HALT HCC LA Planning Committee and will feature exciting presentations from international experts. The conference will consist of a series of multidisciplinary panel discussions and a practical case review with ample time for direct interaction and Q&A sessions for each topic.


  • When

  • Saturday, April 14, 2018
    7:30 AM - 3:15 PM
    Pacific SA Time

  • Where

  • HMRI Biomedical Research Center
    686 S Fair Oaks Ave
    Pasadena, California 91105

CME Information

Target Audience
This activity has been designed to meet the educational needs of physicians, surgeons, physician assistants, nurse practitioners and allied health professionals involved in the care of patients with hepatocellular carcinoma (HCC)

Educational Objectives
Upon completion of this symposium, participants should be better able to:
  • Explain data on the prevalence, etiologies and consequences of HCC in the general and underserved and minority populations
  • Discuss accepted screening classification systems and analyze how disease classification dictates treatment
  • Interpret the role and benefits of utilizing a multidisciplinary approach when treating and managing HCC
  • Critique and compare current HCC treatment modalities including surgery, ablative therapies and systemic treatments

Credit Designation

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the New Mexico Medical Society (NMMS) through the joint providership of the Rehoboth McKinley Christian Health Care Services (RMCHCS) and Huntington Medical Research Institutes (HMRI).  RMCHCS is accredited by NMMS to provide continuing medical education for physicians. 

RMCHCS designates this live activity for a maximum of 6.0 AMA PRA Category 1 Credits™. Physicians should claim only the credits commensurate with the extent of their participation in the activity.  

Rehoboth logo 

Jointly provided by Rehoboth McKinley Christian Health Care Services (RMCHCS) 
and Huntington Medical Research Institutes (HMRI). 

This activity is supported by an independent medical education grant from Bristol-Myers Squibb.

Outlook Outlook
iCal iCal
Google Google
Yahoo! Yahoo!